CD46 and cervical cancer: The experimental results confirm that ATG4D, CD46, TP73 and HSPB8 are decreased in cervical cancer, and the prognosis model shows a negative correlation with the risk score, it could be inferred that they had a protective effect on the occurrence and prognosis of cervical cancer.